Affordable Access

deepdyve-link
Publisher Website

IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells.

Authors
  • Santarlasci, Veronica1
  • Maggi, Laura
  • Mazzoni, Alessio
  • Capone, Manuela
  • Querci, Valentina
  • Rossi, Maria Caterina
  • Beltrame, Luca
  • Cavalieri, Duccio
  • De Palma, Raffaele
  • Liotta, Francesco
  • Cosmi, Lorenzo
  • Maggi, Enrico
  • Romagnani, Sergio
  • Annunziato, Francesco
  • 1 Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, Florence, Italy. , (Italy)
Type
Published Article
Journal
European Journal of Immunology
Publisher
Wiley (John Wiley & Sons)
Publication Date
Mar 01, 2014
Volume
44
Issue
3
Pages
654–661
Identifiers
DOI: 10.1002/eji.201344047
PMID: 24307243
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Human Th17 cells have a limited proliferative capacity compared to other T-cell subsets. We have shown that human Th17 cells display impaired IL-2 production due to IL-4-induced gene 1 (IL4I1) upregulation. Here, we show that in human Th17 cells, IL4I1 also maintains high levels of Tob1, a member of the Tob/BTG (B-cell traslocation gene) antiproliferative protein family, which prevents cell-cycle progression mediated by TCR stimulation. Indeed, Th17 cells exhibited higher levels of Tob1 than Th1 cells in both resting and TCR-activated conditions. Accordingly, the expression of positive regulators of the cell cycle (cyclin A, B, C, and E and Cdk2), as well as of Skp2, which promotes Tob1 degradation, was lower in Th17 cells than in Th1 cells. Tob1 expression in human Th17 cells correlated with both RAR (retinoic acid receptor)-related orphan receptor C (RORC) and IL4I1 levels. However, RORC was not directly involved in the regulation of Tob1 expression, whereas IL4I1 silencing in Th17 cells induced a substantial decrease of Tob1 expression. These data suggest that IL4I1 upregulation in human Th17 cells limits their TCR-mediated expansion not only by blocking the molecular pathway involved in the activation of the IL-2 promoter, but also by maintaining high levels of Tob1, which impairs entry into the cell cycle. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Report this publication

Statistics

Seen <100 times